Monthly Archives :

October 2017

On the Road to Eliminating RSV
On the Road to Eliminating RSV 150 150 Abbie Roth

With the recent publication of two papers, researchers shed light on factors that influence disease severity and immune response to respiratory syncytial virus infection in infants and young children. “RSV is a very common infection in infants and young children – almost everyone will be infected by age 2. In the United States, 2-3 percent…

read more
8 Ways You Can Support Families in Need of Behavioral Health Services
8 Ways You Can Support Families in Need of Behavioral Health Services 150 150 Nancy Cunningham, PsyD

Long wait times and difficulties accessing behavioral health services cause stress for many patients and families. As awareness grows about the prevalence of behavioral health challenges for children and adolescents, more patients and families are seeking specialized care. However, due to a shortage of behavioral health specialists, wait times can seem daunting. As the pediatrician,…

read more
How Genes and Environment Interact to Raise Risk of Congenital Heart Defects
How Genes and Environment Interact to Raise Risk of Congenital Heart Defects 150 150 Mary Bates, PhD

Genetic susceptibility plus maternal hyperglycemia interact to contribute to heart defects during fetal development. Infants of mothers with diabetes have a three- to five-fold increased risk of congenital heart defects. Such developmental defects are likely caused by a combination of genetic and environmental factors. However, the molecular mechanisms by which maternal diabetes disrupts normal heart…

read more
Vulnerable Population Lacks Access to Beneficial Puberty-Blocking Hormone Therapy
Vulnerable Population Lacks Access to Beneficial Puberty-Blocking Hormone Therapy 150 150 Jeb Phillips

Transgender youth are often denied access to puberty-blocking hormones because insurance companies decline to cover costs, according to a new study. Transgender youth are often denied access to puberty-blocking hormone therapy that may benefit them because insurance companies decline to cover costs for those patients, a study drawn from cases at Nationwide Children’s Hospital suggests.…

read more
Dopamine: A Rescue Therapy for Fontan Patients With Protein-Losing Enteropathy?
Dopamine: A Rescue Therapy for Fontan Patients With Protein-Losing Enteropathy? 150 150 Jeb Phillips

Patients with quickly worsening PLE saw serum albumin levels stabilize after dopamine treatment. Patients who have undergone the Fontan procedure for single ventricle congenital heart disease do not often develop protein-losing enteropathy (PLE) – but those who do are at substantial risk of mortality and morbidity. Only heart transplant has been shown to alleviate PLE…

read more
Speedy Development of Support Programs for Second Victims Demands Collaboration
Speedy Development of Support Programs for Second Victims Demands Collaboration 150 150 John Hofmeister

Openly sharing research and resources results in rapid development and growth of peer program for health care workers experiencing second victim phenomena. A career in health care brings many rewards — but it also puts its practitioners at risk for depression, anxiety, shame or career burnout whenever a medical error occurs or a patient experiences…

read more